FIELD: pharmacology.SUBSTANCE: (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide or a pharmaceutically acceptable salt thereof is administered in an effective daily dose. Treatment takes at least 12 weeks.EFFECT: effective treatment of cognitive impairment in patients with mild to moderate cognitive impairment who have a subnormal value for one or more cognitive assessment tests.40 cl, 19 tbl, 15 dwg
METHODS FOR COGNITIVE FUNCTION SUPPORT, TREATMENT OR IMPROVEMENT